ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jan 24, 2025
Dividend Increases/Decreases for the Week of January 24
Let's take a look at firms raising/lowering their dividends this week.
Jan 23, 2025
Procter & Gamble on Track to Deliver on Fiscal Year Guidance
Image Source: Procter & Gamble. Looking to fiscal 2025 guidance, all-in sales growth is expected in the range of 2%-4% versus the prior year. Organic growth for the fiscal year is targeted in the range of 3%-5%. P&G reiterated its core earnings per share growth for the fiscal year to be in the range of 5%-7%, equating to a range of $6.91-$7.05, or a 6% increase at the midpoint. In fiscal 2025, P&G expects to pay around $10 billion in dividends and repurchase $6-$7 billion of common shares. At the time of this writing, shares of P&G yield ~2.5%.
Jan 23, 2025
Kinder Morgan Is Now Covering Cash Dividends Paid with Free Cash Flow
Image: Kinder Morgan’s shares have been on a tear after the midstream energy giant reports healthier free cash flow that covers cash dividends paid.Kinder Morgan is doing a much better job covering dividends with traditional free cash flow these days. For the three months ended December 31, 2024, cash flow from operations was $1.51 billion, with capital expenditures coming in at $772 million, resulting in free cash flow of $738 million, which was in excess of the company’s cash dividends paid of $642 million in the quarter. For the year ended December 31, 2024, free cash flow was $3 billion, which was in excess of cash dividends paid of $2.6 billion, resulting in free cash flow after cash dividends paid of $449 million.
Jan 22, 2025
Netflix Records Biggest Quarter of Net Adds in Its History
Image Source: Netflix. Looking to 2025, Netflix expects revenue to be between $43.5-$44.5 billion (12%-14% year-over-year growth), up $500 million from its prior forecast (despite foreign currency headwinds) and an operating margin of 29%, up one percentage point from its prior forecast and two percentage points higher than the 27% operating margin in 2024. Management noted that the return in 2025 of its biggest shows (Squid Game, Wednesday and Stranger Things) gives it optimism heading into the new year.
Jan 17, 2025
UnitedHealth Group’s 2025 Outlook Remains Robust
Image: UnitedHealth Group’s shares have been choppy the past couple years. UnitedHealth Group reaffirmed its outlook for 2025 that it established in December 2024. Revenues for 2025 are anticipated in the range of $450-$455 billion (the midpoint below consensus of $455.6 billion), net earnings are targeted in the range of $28.15-$28.65, and adjusted net earnings are expected in the range of $29.50-$30.00 per share (the midpoint below consensus of $29.86 per share). Cash flow from operations is anticipated to increase to the range of $32-$33 billion, up materially from 2024. We continue to like UnitedHealth’s growth potential and free cash flow generation, and the company remains a core holding in the Best Ideas Newsletter portfolio.
Jan 17, 2025
Dividend Increases/Decreases for the Week of January 17
Let's take a look at firms raising/lowering their dividends this week.
Jan 16, 2025
Taiwan Semiconductor's Results Showcase Strong Growth
Image Source: TSM. Looking to the first quarter of 2025, TSM expects revenue to be between US$25-US$25.8 billion based on the exchange rate assumption of 1 U.S. dollar to 32.8 NT dollars. This was above consensus calling for US$24.75 billion in revenue in the quarter. Gross profit margin is targeted between 57% and 59%, while operating profit margin is expected to be between 46.5%-48.5%. All told, we continue to like TSM’s strong top-line growth and free cash flow generation, and the firm remains a core idea in the ESG Newsletter portfolio.
Jan 15, 2025
Bank Earnings Roundup: C, WFC, GS, JPM
Image Source: Hakan Dahlstrom. Citigroup launches a new, multi-year program to repurchase $20 billion in stock, Wells Fargo puts up strong earnings growth in the fourth quarter, Goldman Sachs issued a blockbuster fourth quarter report, while JPMorgan CEO Jamie Dimon warns of inflation and geopolitical risks.
Jan 14, 2025
KB Home’s Outlook for 2025 Better Than Expected
Image: KB Home’s shares have done well since the beginning of 2023. Looking to fiscal 2025, KB Home's housing revenue is expected in the range of $7.00-$7.5 billion, compared to the consensus forecast of $6.89 billion, with the average selling price in the range of $488,000-$498,000. Homebuilding operating income as a percentage of revenues is targeted at roughly 10.7%, which assumes no inventory-related charges. For the year, housing gross profit margin is targeted in the range of 20.0%-21.0% and assumes no inventory-related charges. Selling, general, and administrative expenses as a percentage of housing revenues is expected in the range of 9.6%-10.0%. We liked KB Home’s fourth quarter results and outlook for fiscal 2025 and what they imply with respect to the health of the housing market. KB Home doesn’t make the cut for any newsletter portfolio, however.
Jan 13, 2025
Walgreens Reports Better Than Feared Results, Shares Yield 8.5%
Image Source: Walgreens. Looking to 2025, Walgreens maintained its adjusted earnings per share guidance of $1.40-$1.80 (consensus was at $1.53), noting “growth in U.S. Healthcare and International segments more than offset by a decline in U.S. Retail Pharmacy, a higher adjusted effective tax rate, and lower contributions from sale-leaseback and Cencora earnings.” Shares of Walgreens are trading at just 7.4x current fiscal year earnings, while boasting a yield of 8.5% at the time of this writing. Though improving, free cash flow continues to be negative at Walgreens, however, and while its dividend is far from safe after its dividend cut, the company is working aggressively to get things back on track.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.